Description:

S1007 Chemotherapy Form (S1007CHEMO) Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=90C9DFFB-23F1-84DB-E040-BB89AD437DC2

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=90C9DFFB-23F1-84DB-E040-BB89AD437DC2

Keywords:
Versions (2) ▾
  1. 8/26/12
  2. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Breast Cancer NCT01272037 Treatment - S1007 Chemotherapy Form (S1007CHEMO) - 3139708v1.0

Instructions: Submit this form at the completion of chemotherapy. All dates are MONTH, DAY, YEAR. Explain any blank fields or blank dates in the Comments section. Place an X in appropriate boxes. Circle AMENDED items in red and write AMENDED across top of form

Header
Unnamed2
Chemotherapy Regimen (select one; if drugs were substituted or omitted during treatment because of toxicity, indicate the initial planned regimen)
Was chemotherapy ever delayed or reduced because of toxicity
Comments

Similar models